Benoxaprofen, formerly known as Benoxaphen, is a non-steroidal anti-inflammatory drug developed by Eli Lilly and Company. Lilly suspended sales of Oraflex in 1982 after reports from the British government and the U.S. Food and Drug Administration (FDA) of adverse effects and deaths linked to the drug. References: Chin KY, El-Kayat B, Milne A, Hart A. Melanoma diagnosed 27 years after a benoxaprofen-induced photosensitivity reaction. J Dermatol Case Rep. 2012 Mar 27;6(1):5-7. doi: 10.3315/jdcr.2012.1087. PubMed PMID: 22514582; PubMed Central PMCID: PMC3322102.

纯度：≥98%

CAS：51234-28-7